Literature DB >> 15582270

Increasing trends of cervical adenocarcinoma incidence in Central Italy despite Extensive Screening Programme, 1985-2000.

Carmen B Visioli1, Marco Zappa, Stefano Ciatto, Anna Iossa, Emanuele Crocetti.   

Abstract

Incidence rates of adenocarcinoma of the uterine cervix have been reported to be increasing in several countries, but not in Italy. The aim of the present study was to analyse trends in cervical cancer incidence by histological type in two districts of Central Italy (Florence and Prato), covered by the Tuscany Cancer Registry (RTT), where cytological screening had been available since the 1970s. Incident cervical cancers during 1985-2000 were 1012. Estimated Annual Percent Change (EAPC) by age-groups and histological type were computed. Incidence increased for adenocarcinoma (EAPC = +5.7%; 95% confidence interval (CI)+2.8; +8.6); whereas, it decreased for squamous cancer (EAPC = -1.9%; 95% CI-3.8; 0) and for other or not specified types (EAPC = -4.4%; 95% CI-10.0; +1.5). Adenocarcinoma increased significantly among younger women (<55 years) but not among older ones, whereas squamous cell cancer decreased among older women only. The burden of cervical cancers might increase in the future if no specific preventive strategies for adenocarcinoma are implemented.

Entities:  

Mesh:

Year:  2004        PMID: 15582270     DOI: 10.1016/j.cdp.2004.07.007

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  13 in total

1.  Prospective study of human papillomavirus and risk of cervical adenocarcinoma.

Authors:  Lisen Arnheim Dahlström; Nathalie Ylitalo; Karin Sundström; Juni Palmgren; Alexander Ploner; Sandra Eloranta; Carani B Sanjeevi; Sonia Andersson; Thomas Rohan; Joakim Dillner; Hans-Olov Adami; Pär Sparén
Journal:  Int J Cancer       Date:  2010-10-15       Impact factor: 7.396

2.  A birth cohort analysis of the incidence of adenocarcinoma of the uterine cervix in the USA.

Authors:  Cairong Zhu; Bryan A Bassig; Yawei Zhang; Kunchong Shi; Peter Boyle; Ni Li; Tongzhang Zheng
Journal:  Eur J Cancer Prev       Date:  2015-05       Impact factor: 2.497

3.  Clinicopathological and Molecular Differences Between Gastric-type Mucinous Carcinoma and Usual-type Endocervical Adenocarcinoma of the Uterine Cervix.

Authors:  Hera Jung; Go Eun Bae; Hye Min Kim; Hyun-Soo Kim
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

4.  High methylation of ZNF582 in cervical adenocarcinoma affects radiosensitivity and prognosis.

Authors:  Na-Yi Yuan Wu; Xiaoyun Zhang; Tangyuan Chu; Songlin Zhu; Yuping Deng; Yi Zhou; Ying Wang; Xueheng Zhao; Lu Liu; Chao Fang; Yang Wang; Yu-Ligh Liou; Jingting Cai; Jing Wang
Journal:  Ann Transl Med       Date:  2019-07

5.  Trends in breast, ovarian and cervical cancer incidence in Mumbai, India over a 30-year period, 1976-2005: an age-period-cohort analysis.

Authors:  P K Dhillon; B B Yeole; R Dikshit; A P Kurkure; F Bray
Journal:  Br J Cancer       Date:  2011-08-09       Impact factor: 7.640

6.  Effectiveness of national cervical cancer screening programme in Taiwan: 12-year experiences.

Authors:  Y-Y Chen; S-L You; C-A Chen; L-Y Shih; S-L Koong; K-Y Chao; M-L Hsiao; C-Y Hsieh; C-J Chen
Journal:  Br J Cancer       Date:  2009-06-16       Impact factor: 7.640

7.  HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies.

Authors:  Paolo Giorgi Rossi; Mario Sideri; Francesca Maria Carozzi; Amina Vocaturo; Franco Maria Buonaguro; Maria Lina Tornesello; Elena Burroni; Luciano Mariani; Sara Boveri; Leandra Maria Zaffina; Francesco Chini
Journal:  Infect Agent Cancer       Date:  2012-10-12       Impact factor: 2.965

8.  Prognostic value of histopathology and trends in cervical cancer: a SEER population study.

Authors:  Vincent Vinh-Hung; Claire Bourgain; Georges Vlastos; Gábor Cserni; Mark De Ridder; Guy Storme; Anne-Thérèse Vlastos
Journal:  BMC Cancer       Date:  2007-08-23       Impact factor: 4.430

9.  Significant decrease of adenocarcinoma in situ not reflected in cervical adenocarcinoma incidence in the Netherlands 1989-2003.

Authors:  H P van de Nieuwenhof; L F A G Massuger; J A de Hullu; M A P C van Ham; J A A M van Dijck; A G Siebers; R L M Bekkers
Journal:  Br J Cancer       Date:  2008-01-08       Impact factor: 7.640

10.  Results of cytology and high-risk human papillomavirus testing in females with cervical adenocarcinoma in situ.

Authors:  Sonia Andersson; Miriam Mints; Erik Wilander
Journal:  Oncol Lett       Date:  2013-05-15       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.